MADISON, Wis.--(BUSINESS WIRE)--Archeus Technologies, a company developing radiopharmaceutical therapies for the treatment of patients with cancer, today announced that the U.S. Food and Drug ...
Archeus Technologies, a clinical-stage company advancing a portfolio of differentiated small-molecule radiopharmaceutical therapies (RPTs) to address some of the most difficult-to-treat cancers, today ...
Archeus Technologies Receives FDA Clearance of Investigational New Drug Application for ART-101 in Development for the Treatment of Prostate Cancer – Company positioned to initiate multiple Phase 1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback